Evidence map›Paper›PMID 40034676›Full record

ArticlePeerJ2025

Development and validation of a nomogram predicting multidrug-resistant tuberculosis risk in East China.

Fang He, Shu Wang, Hua Wang, Xing Ding, Pengfei Huang, Xiaoyun Fan

Abstract readValidation Study
In one paragraph

Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fang HeDepartment of Geriatric Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Shu WangDepartment of Geriatrics, The Third Affiliated Hospital of Anhui Medical University/Hefei First People's Hospital, Hefei, Anhui, China.
Hua WangDepartment of Tuberculosis Diseases, Anhui Chest Hospital, Hefei, Anhui, China.
Xing DingDepartment of Tuberculosis Diseases, Anhui Provincial Hospital Infection District, Hefei, Anhui, China.
Pengfei HuangDepartment of Tuberculosis Diseases, Anhui Chest Hospital, Hefei, Anhui, China.
Xiaoyun FanDepartment of Geriatric Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Multidrug-resistant tuberculosis (MDR-TB) is a global health threat. Our study aimed to develop and externally validate a nomogram to estimate the probability of MDR-TB in patients with TB. Methods: A total of 453 patients with TB in Anhui Chest Hospital between January 2019 and December 2020 were included in the training cohort. In addition, 116 patients with TB from Anhui Provincial Hospital Infection District between January 2015 and November 2023 were included in the validation cohort. Multivariable logistic regression analysis was applied to build a predictive model by combining the feature selected in the least absolute shrinkage and selection operator regression model. The Results: Eight variables of patients with TB were selected using the best penalization parameter of the LASSO regression method, and the nomogram was established. The model displayed good discrimination with a Conclusion: In this study, we constructed the LASSO regression model based on eight clinical traits and outcomes of laboratory tests, providing a novel insight for evaluating MDR-TB.

Indexed as

NomogramsTuberculosis, Multidrug-ResistantAdultAgedChinaFemaleHumansLogistic ModelsMaleMiddle AgedRisk AssessmentRisk FactorsDrug resistant pulmonary tuberculosisEast ChinaNomogramPredictionRisk factors

Identifiers

PMID40034676
PMCPMC11874934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.